Headline News about 2seventy bio, Inc. - Common Stock
![](/next-assets/images/schema-image-default.png)
![](/next-assets/images/schema-image-default.png)
Where 2seventy bio Stands With Analysts
March 17, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/10/tsvt_logo_light__087e409dff50eabf89dc476b6b860046.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_26.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1026.png?width=1200&height=800&fit=crop)
Expert Ratings for 2seventy bio
January 10, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29345.jpeg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23992.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_23815.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_28900.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/10/bz-pharma_3.jpg?width=1200&height=800&fit=crop)
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/10/biotech11.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/10/aapharma_7.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/handbag-purse-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_9637.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_10476.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_4337.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3886.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3716.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_2536.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_1860.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_709.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3076.png)
![](https://stocknews.com/cdn-cgi/image/fit=scale-down,format=auto,q=50,onerror=redirect,height=540/https://stocknews.com/wp-content/uploads/2021/11/shutterstock_757996678-1-scaled.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/movers_image_5431.jpeg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_506.jpeg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_188.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.